In each of 2 cases reported, the patient presented with features of erosive
lichen planus or lichenoid drug eruptions and an incisional biopsy taken f
rom the patient was diagnosed histologically as lichen planus. Subsequent r
ecurrences or exacerbations were associated with vesiculobullous lesions. S
imultaneous or subsequent direct immunofluorescence studies from the same t
issue sample in one case and from a similar site in the other case-demonstr
ated classic features of linear IgA disease. Both patients were originally
treated for lichen planus with systemic and/or topical corticosteroids with
limited success. One patient was treated with sulfapyridine with minimal i
mprovement. Both patients were subsequently treated with dapsone and demons
trated significant clinical improvement. We propose that linear IgA disease
may be more common than reported in the oral cavity, inasmuch as many case
s of recalcitrant lichen planus, erosive lichen planus, and lichenoid drug
eruptions, especially those with a vesiculobullous component, may in realit
y represent linear IgA disease. We recommend that direct immunofluorescence
be done in any case in which bullous lichen planus is suspected.